Krebs Biochemicals and Industries Ltd (KBIL) is a biochemical company that establishes commercially viable biotech processes for application in medicine, agriculture and industry. It was established in the 1991 and is headquartered in Hyderabad. Presently, it has two manufacturing plants - Unit 1 based in Nellore and Unit 2 based in Vizag.
KBIL has expertise and infrastructure in the areas of chemical synthesis, fermentation and enzymatic technologies. It also focuses on cost and quality, which makes it a logical partner for the development and supply of products made using one or more of these technologies. KBIL strives to ensure all its manufacturing is conducted in line with the current Good Manufacturing Practices. It adopts and implements the guidelines of ICH, APIC and other regulatory authorities.
Krebs Biochemicals and Industries Ltd: Quality Manufacturers of Biochemicals
|2007||Vizag plant is inspected and approved by EDQM and AFFSAPS (French Health Authority)|
|2006||Ranbaxy takes strategic stake in KBIL to utilise capacity freed up in Unit 1|
|2004||Commissions stackable potato chip plant in Hyderabad as part of its Food Division|
|2003||Commissions 2.5 MW cogeneration power plant at Unit 2 in Vizag|
|1999||Commissions plant in Vizag and starts commercial production of Anti-cholesterols|
|1994||Commissions plant in Nellore and starts commercial production of Anti-asthmatics|